Cytological and spectroscopic characteristics of c-KIT N822K mutation in core binding factor acute myeloid leukemia cells

被引:6
|
作者
Chen, Yang [1 ]
Wang, Lingyan [2 ]
Lin, Xindi [1 ]
Zhang, Qian [1 ]
Xu, Yunchao [3 ]
Lin, Donghong [1 ]
Xu, Jianping [1 ]
Feng, Shangyuan [3 ]
Hu, Jianda [1 ,2 ]
机构
[1] Fujian Med Univ, Dept Lab Med, 88 Jiaotong RD, Fuzhou, Peoples R China
[2] Fujian Med Univ, Fujian Inst Hematol, Dept Hematol, Fujian Prov Key Lab Hematol,Union Hosp, Fuzhou, Peoples R China
[3] Fujian Normal Univ, Key Lab Optoelect Sci & Technol Med, Minist Educ, Fuzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
CBF-AML; chromosome translocation; c-KIT N822K mutation; flow cytometry; laser tweezers Raman spectroscopy; LOOP TYROSINE 823; RAMAN-SPECTROSCOPY; ACTIVATION LOOP; TWEEZERS; SURVIVAL;
D O I
10.1002/jbio.202000103
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The frequency of N822K mutation is high in the A-loop region of c-KIT which is highly associated with poor prognosis of core binding factor acute myeloid leukemia. The current work used common assays including cell cycle, apoptosis, clone formation and western blot to perform cytological detection for HL60 (wild type), NB4 (carrying t[15;17] chromosome translocation) and Kasumi-1 (with c-KIT N822K mutation); and meanwhile, the laser tweezers Raman spectroscopy (LTRS) was also used to perform label-free detection of single living cells. The results demonstrated that Kasumi-1 cell line bearing c-KIT N822K mutation has a stable cell cycle, while there was a significant difference between early and late apoptosis within 48 hours. The LTRS detection initially reflected the spectral differences induced by genetic abnormalities and highlighted progressive patterns of DNA and amino acids band contents which were appropriately consistent with that of cell clone ratio and the c-KIT phosphorylation level. It is concluded that methodology of LTRS-based single living cell characterization could be potential and effective to reveal gene mutation-induced cell differentiation.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Core-binding factor acute myeloid leukemia in pediatric patients enrolled in the AIEOP AML 2002/01 trial: screening and prognostic impact of c-KIT mutations
    E Manara
    V Bisio
    R Masetti
    V Beqiri
    R Rondelli
    G Menna
    C Micalizzi
    N Santoro
    F Locatelli
    G Basso
    M Pigazzi
    Leukemia, 2014, 28 : 1132 - 1134
  • [32] Prevalence and prognostic significance of c-KIT mutations in core binding factor acute myeloid leukemia: A comprehensive large-scale study from a single Chinese center
    Qin, Ya-Zhen
    Zhu, Hong-Hu
    Jiang, Qian
    Jiang, Hao
    Zhang, Le-Ping
    Xu, Lan-Ping
    Wang, Yu
    Liu, Yan-Rong
    Lai, Yue-Yun
    Shi, Hong-Xia
    Jiang, Bin
    Huang, Xiao-Jun
    LEUKEMIA RESEARCH, 2014, 38 (12) : 1435 - 1440
  • [33] Systemic mastocytosis is uncommon in KIT D816V mutation positive core-binding factor acute myeloid leukemia
    Kristensen, Thomas
    Preiss, Birgitte
    Broesby-Olsen, Sigurd
    Vestergaard, Hanne
    Friis, Lone
    Moller, Michael Boe
    LEUKEMIA & LYMPHOMA, 2012, 53 (07) : 1338 - 1344
  • [34] Core-binding factor acute myeloid leukemia in pediatric patients enrolled in the AIEOP AML 2002/01 trial: screening and prognostic impact of c-KIT mutations
    Manara, E.
    Bisio, V.
    Masetti, R.
    Beqiri, V.
    Rondelli, R.
    Menna, G.
    Micalizzi, C.
    Santoro, N.
    Locatelli, F.
    Basso, G.
    Pigazzi, M.
    LEUKEMIA, 2014, 28 (05) : 1132 - 1134
  • [35] D816 mutation of the KIT gene in core binding factor acute myeloid leukemia is associated with poorer prognosis than other KIT gene mutations
    Yui, Shunsuke
    Kurosawa, Saiko
    Yamaguchi, Hiroki
    Kanamori, Heiwa
    Ueki, Toshimitsu
    Uoshima, Nobuhiko
    Mizuno, Ishikazu
    Shono, Katsuhiro
    Usuki, Kensuke
    Chiba, Shigeru
    Nakamura, Yukinori
    Yanada, Masamitsu
    Kanda, Junya
    Tajika, Kenji
    Gomi, Seiji
    Fukunaga, Keiko
    Wakita, Satoshi
    Ryotokuji, Takeshi
    Fukuda, Takahiro
    Inokuchi, Koiti
    ANNALS OF HEMATOLOGY, 2017, 96 (10) : 1641 - 1652
  • [36] Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia
    B F Goemans
    Ch M Zwaan
    M Miller
    M Zimmermann
    A Harlow
    S Meshinchi
    A H Loonen
    K Hählen
    D Reinhardt
    U Creutzig
    G J L Kaspers
    M C Heinrich
    Leukemia, 2005, 19 : 1536 - 1542
  • [37] D816 mutation of the KIT gene in core binding factor acute myeloid leukemia is associated with poorer prognosis than other KIT gene mutations
    Shunsuke Yui
    Saiko Kurosawa
    Hiroki Yamaguchi
    Heiwa Kanamori
    Toshimitsu Ueki
    Nobuhiko Uoshima
    Ishikazu Mizuno
    Katsuhiro Shono
    Kensuke Usuki
    Shigeru Chiba
    Yukinori Nakamura
    Masamitsu Yanada
    Junya Kanda
    Kenji Tajika
    Seiji Gomi
    Keiko Fukunaga
    Satoshi Wakita
    Takeshi Ryotokuji
    Takahiro Fukuda
    Koiti Inokuchi
    Annals of Hematology, 2017, 96 : 1641 - 1652
  • [38] The Prognostic Impact of KIT D816 Mutations in Core Binding Factor Acute Myeloid Leukemia
    Yui, Shunsuke
    Kurosawa, Saiko
    Yamaguchi, Hiroki
    Kanamori, Heiwa
    Ueki, Toshimitsu
    Uoshima, Nobuhiko
    Mizuno, Ishikazu
    Shono, Katsuhiro
    Usuki, Kensuke
    Okoshi, Yasushi
    Nakamura, Yukinori
    Yanada, Masamitsu
    Kanda, Junya
    Tajika, Kenji
    Gomi, Seiji
    Fukunaga, Keiko
    Wakita, Satoshi
    Ryotokuji, Takeshi
    Fukuda, Takahiro
    Inokuchi, Koiti
    BLOOD, 2016, 128 (22)
  • [39] KIT mutations correlate with adverse survival in children with core-binding factor acute myeloid leukemia
    Chen, Xi
    Dou, Hu
    Wang, Xingjuan
    Huang, Yi
    Lu, Ling
    Bin, Junqing
    Su, Yongchun
    Zou, Lin
    Yu, Jie
    Bao, Liming
    LEUKEMIA & LYMPHOMA, 2018, 59 (04) : 829 - 836
  • [40] Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia
    Goemans, BF
    Zwaan, CM
    Miller, M
    Zimmermann, M
    Harlow, A
    Meshinchi, S
    Loonen, AH
    Hählen, K
    Reinhardt, D
    Creutzig, U
    Kaspers, GJL
    Heinrich, MC
    LEUKEMIA, 2005, 19 (09) : 1536 - 1542